Predictive Care Opportunity Position the platform as a tool for hospitals and payers to predict high-risk patients and tailor interventions, enabling proactive, personalized care and potential reductions in unnecessary escalations. Use LungFlag and AlgoMarker capabilities as proof points during pilots with large health systems and academic centers, focusing on high burden conditions to demonstrate ROI.

Strategic Partnerships Leverage proven partnerships with Roche and Geisinger to attract pharma and diagnostics collaborators for co-development of AI driven diagnostic tools and trial enrichment solutions. Target additional pharmaceutical companies seeking faster, evidence-based patient stratification and companion diagnostics opportunities.

Remote Care Growth Capitalize on Back2Care and remote care automation to offer end-to-end remote patient monitoring and care management programs. Position to health systems and insurers aiming to reduce readmissions and manage chronic conditions, with turnkey integration into existing care pathways and workflows.

Data Integration Capabilities Highlight data handling and integration strengths to hospital IT teams: scalable AI pipelines, risk scoring across large patient populations, and easy embedding into EHR workflows. Offer professional services for implementation, model monitoring and regulatory compliance to accelerate AI adoption.

Market Expansion Expand go-to-market through targeted expansion into new geographic markets and disease areas, leveraging successful cancer and respiratory care use cases to broaden coverage across additional conditions. Pursue co-selling opportunities with larger partners and forge partnerships with health systems and payers to accelerate scale.